SCHEMBL8085829

SCHEMBL8085829

Cc1cc([N+](=O)[O-])cc2c1=NC(=O)C(=O)N=2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.43
TSHR P16473 4/20 0.43
TDP1 Q9NUW8 3/20 0.43
GPR35 Q9HC97 1/20 0.42
CYP3A4 P08684 2/20 0.41
CYP19A1 P11511 1/20 0.36
HTR1D P28221 1/20 0.36
HTR1B P28222 1/20 0.36
HTT P42858 3/20 0.35
LMNA P02545 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CHEK1 O14757 1/20 0.35
DAPK3 O43293 1/20 0.35
GRK5 P34947 1/20 0.35
LIMK1 P53667 1/20 0.35
MAPT P10636 4/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6838343 0.86 ALDH1A1 (0.36) ALDH1A1TSHRTDP1GPR35CYP3A4
SCHEMBL1269876 0.81 ALDH1A1 (0.42) ALDH1A1TSHRTDP1GPR35CYP3A4
SCHEMBL8085548 0.79 ALDH1A1 (0.43) ALDH1A1TSHRCYP3A4CYP19A1HTT
SCHEMBL21292987 0.76 VCAM1 (0.47) ALDH1A1TDP1CYP19A1HTTLMNA
SCHEMBL7344596 0.75 GRIN2D (0.43) ALDH1A1TSHRTDP1MEN1KMT2A
SCHEMBL7352678 0.72 GRIN2D (0.46) ALDH1A1TSHRTDP1HTTLMNA
SCHEMBL1305456 0.71 PTPRC (0.52) ALDH1A1TSHRTDP1GPR35CYP3A4
SCHEMBL7344459 0.70 MAPK1 (0.39) ALDH1A1TSHRTDP1GPR35HTT
SCHEMBL7350934 0.69 GRIN2D (0.46) ALDH1A1TSHRTDP1HTTLMNA
SCHEMBL7351087 0.69 GRIN2D (0.46) ALDH1A1TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6080743-A AS CHEMICAL INTERMEIDATES FOR PREPARING DRUGS NOVARTIS AG (CH) 2000-06-27 US disclosed
EP-0853617-A1 NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES Novartis AG (CH) 1998-07-22 EP disclosed
WO-1997008155-A1 NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES NOVARTIS AG (CH) 1997-03-06 WO disclosed